Loading clinical trials...
Loading clinical trials...
Phase I Trial of Nelfinavir and Bortezomib in Advanced Hematologic Malignancies
Conditions
Interventions
bortezomib
nelfinavir mesylate
Locations
4
Switzerland
Inselspital Bern
Bern, Switzerland
Kantonsspital Graubuenden
Chur, Switzerland
Centre Hospitalier Universitaire Vaudois
Lausanne, Switzerland
Kantonsspital - St. Gallen
Sankt Gallen, Switzerland
Start Date
July 1, 2010
Primary Completion Date
July 1, 2012
Completion Date
November 1, 2013
Last Updated
May 15, 2019
NCT06337318
NCT07388563
NCT05529069
NCT06311227
NCT06263491
NCT06285890
Lead Sponsor
Swiss Cancer Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions